GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (TSXV:VPT) » Definitions » Days Sales Outstanding

VentriPoint Diagnostics (TSXV:VPT) Days Sales Outstanding : 31.16 (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is VentriPoint Diagnostics Days Sales Outstanding?

VentriPoint Diagnostics's average Accounts Receivable for the three months ended in Dec. 2023 was C$0.01 Mil. VentriPoint Diagnostics's Revenue for the three months ended in Dec. 2023 was C$0.04 Mil. Hence, VentriPoint Diagnostics's Days Sales Outstanding for the three months ended in Dec. 2023 was 31.16.

The historical rank and industry rank for VentriPoint Diagnostics's Days Sales Outstanding or its related term are showing as below:

TSXV:VPT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 71.6   Med: 305.12   Max: 425.83
Current: 183.24

During the past 13 years, VentriPoint Diagnostics's highest Days Sales Outstanding was 425.83. The lowest was 71.60. And the median was 305.12.

TSXV:VPT's Days Sales Outstanding is ranked worse than
91.86% of 811 companies
in the Medical Devices & Instruments industry
Industry Median: 64.92 vs TSXV:VPT: 183.24

VentriPoint Diagnostics's Days Sales Outstanding declined from Dec. 2022 (96.14) to Dec. 2023 (31.16).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


VentriPoint Diagnostics Days Sales Outstanding Historical Data

The historical data trend for VentriPoint Diagnostics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics Days Sales Outstanding Chart

VentriPoint Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 236.18 327.76

VentriPoint Diagnostics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 96.14 912.50 570.31 - 31.16

Competitive Comparison of VentriPoint Diagnostics's Days Sales Outstanding

For the Medical Devices subindustry, VentriPoint Diagnostics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VentriPoint Diagnostics's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's Days Sales Outstanding falls into.



VentriPoint Diagnostics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

VentriPoint Diagnostics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.044 + 0) / 1 ) / 0.049*365
=0.044 / 0.049*365
=327.76

VentriPoint Diagnostics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.014 + 0) / 1 ) / 0.041*365 / 4
=0.014 / 0.041*365 / 4
=31.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VentriPoint Diagnostics  (TSXV:VPT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


VentriPoint Diagnostics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


VentriPoint Diagnostics (TSXV:VPT) Business Description

Traded in Other Exchanges
Address
18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.
Executives
Robert Hodgkinson Director

VentriPoint Diagnostics (TSXV:VPT) Headlines

No Headlines